WMT · News · 20261022N

FDA Marketplace Warning

Walmart Inc. · 2026-10-22 · Importance 47 · Surprise 60

The U.S. Food and Drug Administration issued Walmart a warning letter concerning unapproved sexually transmitted infection drug products sold through Walmart's online marketplace. The products were offered by third-party sellers, while Walmart Fulfillment Services handled logistics and delivery. The matter creates regulatory and compliance exposure for Walmart's marketplace governance and pharmaceutical-product controls.

Key facts

• The US Food and Drug Administration issued Walmart a warning letter over unapproved sexually transmitted infection drug products sold on its marketplace that were offered through Walmart's online third party platform using Walmart Fulfillment Services for logistics and delivery. source